Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors

Cheng Mo; Zhang Zhang; Yupeng Li; Minhao Huang; Jian Zou; Jinfeng Luo; Zheng-Chao Tu; Yong Xu; Xiaomei Ren; Ke Ding; Xiaoyun Lu

doi:10.1021/acsmedchemlett.9b00495

Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors

Cheng Mo, Zhang Zhang, Yupeng Li, Minhao Huang, Jian Zou, Jinfeng Luo, Zheng-Chao Tu, Yong Xu, Xiaomei Ren, Ke Ding, Xiaoyun Lu

Carcinogenesis and Chemoprevention

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English
Journal	ACS Medicinal Chemistry Letters
DOIs	https://doi.org/10.1021/acsmedchemlett.9b00495
State	Published - Jan 9 2020

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1021/acsmedchemlett.9b00495

OpenUrl availability

Full text

Cite this

@article{9fe98dea1d524fd4b1b4e5895f726976,

title = "Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors",

author = "Cheng Mo and Zhang Zhang and Yupeng Li and Minhao Huang and Jian Zou and Jinfeng Luo and Zheng-Chao Tu and Yong Xu and Xiaomei Ren and Ke Ding and Xiaoyun Lu",

year = "2020",

month = jan,

day = "9",

doi = "10.1021/acsmedchemlett.9b00495",

language = "English",

journal = "ACS Medicinal Chemistry Letters",

issn = "1948-5875",

publisher = "American Chemical Society",

}

TY - JOUR

T1 - Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors

AU - Mo, Cheng

AU - Zhang, Zhang

AU - Li, Yupeng

AU - Huang, Minhao

AU - Zou, Jian

AU - Luo, Jinfeng

AU - Tu, Zheng-Chao

AU - Xu, Yong

AU - Ren, Xiaomei

AU - Ding, Ke

AU - Lu, Xiaoyun

PY - 2020/1/9

Y1 - 2020/1/9

UR - https://doi.org/10.1021/acsmedchemlett.9b00495

U2 - 10.1021/acsmedchemlett.9b00495

DO - 10.1021/acsmedchemlett.9b00495

M3 - Article

C2 - 32184973

SN - 1948-5875

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

ER -

Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this